ArticleFrontiers in pediatrics2026
Machine learning-based identification of inflammatory biomarkers for predicting pulmonary consolidation in children with Chlamydia pneumoniae infection.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to identify core inflammatory biomarkers through machine learning approaches and develop an accessible online risk calculator to predict pulmonary consolidation in children with Chlamydia pneumoniae infection, addressing the current lack of effective early warning tools. Methods: This retrospective case-control study enrolled 42 children with C. pneumoniae infection (consolidation group: 26 cases; non-consolidation group: 16 cases) between January 2020 and December 2024. Five machine learning algorithms, including least absolute shrinkage and selection operator (LASSO) regression, support vector machine-recursive feature elimination (SVM-RFE), Random Forest, XGBoost, and LightGBM, were employed for feature selection, and core predictive factors were identified through consensus validation across these algorithms. K-means clustering analysis was performed on the key inflammatory markers, and an online risk assessment system based on HTML5 technology was developed. Results: The five machine learning algorithms consistently identified lactate dehydrogenase (LDH), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) as core inflammatory markers for predicting pulmonary consolidation. All three indicators were significantly higher in the consolidation group compared with the non-consolidation group ( Conclusion: LDH, CRP, and ESR are key indicators for predicting pulmonary consolidation in children with C. pneumoniae infection. The online risk assessment system developed based on these three routine laboratory parameters demonstrates good clinical usability and practicality, enabling early identification of high-risk patients to guide individualized treatment decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.